
Amgen announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, featuring executives Peter Griffith and Murdo Gordon. The presentation will be webcast live and accessible to the public, investors, and media via Amgen's website, with the replay available for 90 days. This event highlights Amgen's ongoing innovation in biotechnology and its broad pipeline targeting diseases like cancer, rare diseases, and heart conditions. Investors can follow updates through Amgen's investor relations channels and social media platforms.